$INCY INCYTE CORP Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INCYTE CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in INCYTE CORP. Find out how many shares they currently own, their value and whether they buy or sell their shares.
INCYTE CORP Insiders
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
14159 capital (GP), LLC | Director | 282,354 | 33,368,596 | Sep 28 2009 | |||
14159 capital (GP), LLC | Director | 355,839 | 42,053,053 | Jan 17 2012 | |||
14159 capital (GP), LLC | Director | 237,497 | 28,067,395 | Sep 23 2010 | |||
Andrews Patricia S | Chief Commercial Officer | 0 | 0 | Jan 23 2012 | |||
ARIKO BARRY A | Director | 45,834 | 5,416,662 | Mar 13 2015 | |||
ARIKO BARRY A | Director | 0 | 0 | May 27 2004 | |||
ARIKO BARRY A | Director | 45,834 | 5,416,662 | May 28 2014 | |||
ARIKO BARRY A | Director | 45,834 | 5,416,662 | Feb 20 2015 | |||
Baker Biotech Capital (GP), LLC | Director | 0 | 0 | Sep 28 2009 | |||
Baker Biotech Capital (GP), LLC | Director | 2,933,021 | 346,624,422 | Sep 23 2010 | |||
BAKER BROS ADVISORS LLC | Director | 2,850,042 | 336,817,964 | Oct 02 2020 | |||
Baker Bros. Capital (GP), LLC | Director | 239,258 | 28,275,510 | Sep 23 2010 | |||
Baker Bros. Capital (GP), LLC | Director | 0 | 0 | Sep 28 2009 | |||
Baker Bros. Capital (GP), LLC | Director | 227,594 | 26,897,059 | Jul 05 2011 | |||
Baker Brothers Life Sciences Capital (GP), LLC | Director | 8,929,705 | 1,055,312,537 | Sep 28 2009 | |||
Baker Brothers Life Sciences Capital (GP), LLC | Director | 7,511,046 | 887,655,416 | Sep 23 2010 | |||
Baker Brothers Life Sciences Capital (GP), LLC | Director | 12,430,783 | 1,469,069,935 | Jan 17 2012 | |||
BAKER JULIAN | Director | 3,851,178 | 455,132,216 | Feb 22 2017 | |||
BAKER JULIAN | Director | 0 | 0 | Oct 13 2006 | |||
BAKER JULIAN | Director | 390,839 | 46,189,353 | May 29 2014 | |||
BAKER JULIAN | Director | 1,278,127 | 151,049,049 | May 31 2013 | |||
Baker / Tisch Capital (GP), LLC | Director | 189,909 | 22,443,446 | Sep 28 2009 | |||
Baker / Tisch Capital (GP), LLC | Director | 159,739 | 18,877,955 | Sep 23 2010 | |||
BIENAIME JEAN JACQUES | Director | 8,921 | 1,054,284 | Jan 05 2021 | |||
BIENAIME JEAN JACQUES | Director | 0 | 0 | Jan 22 2015 | |||
BROOKE PAUL A | Director | 221,911 | 26,225,442 | Apr 02 2020 | |||
BROOKE PAUL A | Director | 135,000 | 15,954,300 | May 28 2014 | |||
BROOKE PAUL A | Director | 149,584 | 17,677,837 | Sep 13 2004 | |||
Chardonnet Laurent | VP Finance and Treasurer | 2,905 | 343,313 | Apr 01 2015 | |||
Chardonnet Laurent | 2,905 | 343,313 | Jan 09 2015 | ||||
Clancy Paul J | Director | 5,094 | 602,009 | Apr 01 2021 | |||
Clancy Paul J | Director | 0 | 0 | Jan 22 2015 | |||
CRAVES FRED B | Director | 196,793 | 23,256,997 | Apr 23 2004 | |||
CRAVES FRED B | Director | 0 | 0 | May 27 2004 | |||
CRAVES FRED B | Director | 0 | 0 | Jun 03 2005 | |||
Daly James M | EVP, Chief Commercial Officer | 3,521 | 416,112 | Jun 25 2015 | |||
Daly James M | EVP, Chief Commercial Officer | 0 | 0 | Oct 24 2014 | |||
Daly James M | EVP, Chief Commercial Officer | 3,521 | 416,112 | Jan 26 2015 | |||
DE SCHUTTER RICHARD U | Director | 92,290 | 10,906,832 | Mar 09 2015 | |||
DE SCHUTTER RICHARD U | Director | 105,000 | 12,408,900 | Dec 03 2014 | |||
DE SCHUTTER RICHARD U | Director | 0 | 0 | May 28 2004 | |||
DE SCHUTTER RICHARD U | Director | 25,000 | 2,954,500 | Mar 10 2005 | |||
DE SCHUTTER RICHARD U | Director | 155,000 | 18,317,900 | May 28 2014 | |||
Dhanak Dashyant | EVP & Chief Scientific Officer | 26,940 | 3,183,769 | May 05 2021 | |||
Dickinson Jonathan Elliott | EVP, General Manager, Europe | 27,135 | 3,206,814 | Jan 27 2021 | |||
DIXON WENDY L | Director | 14,878 | 1,758,282 | Apr 01 2021 | |||
Emmens Matthew | Director | 0 | 0 | May 22 2008 | |||
Flannelly Barry P | EVP & General Manager US | 49,994 | 5,908,291 | Jan 27 2021 | |||
Flannelly Barry P | EVP, Business Development | 3,022 | 357,140 | Jan 09 2015 | |||
FOUSE JACQUALYN A | Director | 5,510 | 651,172 | Apr 01 2021 | |||
FRIEDMAN PAUL A | Director | 256,813 | 30,350,160 | May 28 2020 | |||
FRIEDMAN PAUL A | Director | 297,518 | 35,160,677 | Feb 18 2015 | |||
FRIEDMAN PAUL A | Chief Executive Officer | 421,135 | 49,769,734 | Aug 17 2004 | |||
FRIEDMAN PAUL A | Chief Executive Officer | 116,700 | 13,791,606 | Mar 10 2005 | |||
FRIEDMAN PAUL A | Director | 417,518 | 49,342,277 | May 28 2014 | |||
Friedman Steven M. | EVP, Biology & Preclinical Dev | 38,137 | 4,507,031 | May 20 2010 | |||
GRYSKA DAVID W | Executive Vice President, CFO | 10,235 | 1,209,572 | Jul 18 2018 | |||
GRYSKA DAVID W | Executive Vice President, CFO | 10,850 | 1,282,253 | Jan 09 2015 | |||
HARRIGAN EDMUND | Director | 2,711 | 320,386 | Apr 01 2021 | |||
HASTINGS DAVID C | Exec VP & CFO | 0 | 0 | Feb 18 2004 | |||
HASTINGS DAVID C | Exec VP & CFO | 0 | 0 | Jan 27 2005 | |||
HASTINGS DAVID C | Chief Financial Officer | 8,500 | 1,004,530 | Jun 06 2014 | |||
High Katherine A | Director | 1,421 | 167,934 | May 28 2020 | |||
Hoppenot Herve | Chairman / CEO | 284,231 | 33,590,420 | Feb 23 2021 | |||
Hoppenot Herve | Chief Executive Officer | 382,058 | 45,151,614 | Feb 18 2015 | |||
Huber Reid M | EVP, Chief Scientific Officer | 34,571 | 4,085,601 | Jul 18 2018 | |||
Huber Reid M | EVP, Chief Scientific Officer | 44,562 | 5,266,337 | Jan 09 2015 | |||
HURLEY SCOTT W | 0 | 0 | Feb 04 2004 | ||||
HURLEY SCOTT W | 0 | 0 | Jan 27 2005 | ||||
INCYTE CORP | 10% Owner | 3,550,000 | 419,539,000 | Jan 25 2021 | |||
Iyengar Vijay K | EVP GPS, BD, & Licensing | 31,274 | 3,695,961 | Jan 27 2021 | |||
KELLER JOHN A | Exec VP & Chief Bus Officer | 0 | 0 | Feb 18 2004 | |||
KELLER JOHN A | Exec VP & Chief Bus Officer | 0 | 0 | Jan 27 2005 | |||
KELLER JOHN A | Chief Business Officer | 0 | 0 | Feb 11 2008 | |||
Levy Richard S | EVP, Chief Drug Dev Officer | 16,926 | 2,000,315 | Jan 08 2016 | |||
Levy Richard S | EVP, Chief Drug Dev&Medical Of | 18,205 | 2,151,467 | Feb 18 2015 | |||
METCALF BRIAN W | 0 | 0 | Feb 19 2004 | ||||
METCALF BRIAN W | 0 | 0 | Jan 27 2005 | ||||
METCALF BRIAN W | Chief Drug Discovery Scientist | 66,504 | 7,859,443 | Apr 13 2011 | |||
Morrissey Michael James | EVP, Head of Tech. Operations | 45,452 | 5,371,517 | Mar 31 2021 | |||
NIBLACK JOHN F | Director | 0 | 0 | May 20 2010 | |||
NIBLACK JOHN F | Director | 0 | 0 | May 23 2011 | |||
Pasquale Maria E | EVP & General Counsel | 29,938 | 3,538,073 | Apr 27 2021 | |||
SAXE JON S | Director | 80,000 | 9,454,400 | Apr 01 2004 | |||
SCHRECK PATRICIA A | EVP and General Counsel | 0 | 0 | Jan 27 2005 | |||
SCHRECK PATRICIA A | EVP, General Counsel | 4,500 | 531,810 | May 11 2011 | |||
Siegel Eric H. | EVP, General Counsel | 21,053 | 2,488,044 | Sep 15 2017 | |||
Siegel Eric H. | EVP, General Counsel | 3,355 | 396,494 | Jan 26 2015 | |||
Stamoulis Christiana | EVP & Chief Financial Officer | 33,821 | 3,996,966 | Jan 20 2021 | |||
Stein Steven H | EVP & Chief Medical Officer | 123,539 | 14,599,839 | Jan 27 2021 | |||
SWAIN PAULA J | EVP, Human Resources | 52,781 | 6,237,659 | Jan 20 2021 | |||
SWAIN PAULA J | 0 | 0 | Jan 27 2005 | ||||
SWAIN PAULA J | EVP, Human Resources | 18,061 | 2,134,449 | Feb 18 2014 | |||
SWAIN PAULA J | EVP, Human Resources | 21,083 | 2,491,589 | Feb 18 2015 | |||
TISCH ANDREW H | 10% Owner | 1,216,661 | 143,784,997 | Aug 13 2004 | |||
TISCH DANIEL R | 10% Owner | 1,216,661 | 143,784,997 | Aug 13 2004 | |||
TISCH JAMES S | 10% Owner | 1,216,661 | 143,784,997 | Aug 13 2004 | |||
TISCH THOMAS J | 10% Owner | 1,416,661 | 167,420,997 | Aug 13 2004 | |||
Trower Paul | Principal Accounting Officer | 28,427 | 3,359,503 | Jan 20 2021 | |||
Wenqing Yao | EVP, Head of Discovery Chem | 145,343 | 17,176,636 | Jan 27 2021 | |||
WHITFIELD ROY A | Director | 983,389 | 116,216,912 | Mar 11 2005 | |||
WHITFIELD ROY A | Director | 666,082 | 78,717,571 | Dec 19 2013 |